Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head and Neck Cancer
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Procedure: Computed Tomography; Procedure: Lymphoscintigraphy; Drug: Panitumumab-IRDye800; Other: Pharmacological Study; Procedure: Single Photon Emission Computed Tomography; Radiation: Technetium Tc 99m-labeled Tilmanocept Sponsors: Eben Rosenthal; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Head and Neck Cancer | Lymphoscintigraphy | Research | SPECT | Study